Skip to main content

Tei Index (Myocardial Performance Index) in Echocardiography

Tei Index (Myocardial Performance Index) in Echocardiography

The Tei index, also known as the Myocardial Performance Index (MPI), is a simple, reproducible echocardiographic parameter that integrates systolic and diastolic ventricular function into a single numerical value. It is widely used for both left and right ventricular functional assessment and is relatively independent of heart rate and ventricular geometry.



---


What Is the Tei Index?


The Tei index reflects global ventricular performance by combining time intervals from Doppler echocardiography.


Formula:


\text{Tei Index (MPI)} = \frac{\text{IVCT} + \text{IVRT}}{\text{ET}}


Where:


IVCT = Isovolumic contraction time


IVRT = Isovolumic relaxation time


ET = Ejection time



A higher Tei index indicates worse ventricular function.



---


How Is Tei Index Measured on Echocardiography?


1. Pulsed-Wave Doppler Method (Conventional)


Place PW Doppler at mitral inflow (LV) or tricuspid inflow (RV)


Measure interval ‘a’ = time from end of one inflow to onset of the next inflow

(includes IVCT + ET + IVRT)


Measure interval ‘b’ = ventricular ejection time from LVOT or RVOT


Calculate:



\text{Tei Index} = \frac{a - b}{b}


2. Tissue Doppler Imaging (TDI) Method


Place TDI sample at mitral annulus (LV) or tricuspid annulus (RV)


Measure:


IVCT


IVRT


ET directly from annular velocity waveform



Less affected by loading conditions and heart rate variability




---


Normal Values


Ventricle Normal Tei Index


Left ventricle ≤ 0.40

Right ventricle ≤ 0.43



Values above these thresholds suggest global ventricular dysfunction.



---


Clinical Applications


Heart failure (HFrEF and HFpEF)


Dilated cardiomyopathy


Ischemic heart disease


Pulmonary hypertension (RV MPI)


Congenital heart disease


Valvular heart disease


Post–myocardial infarction prognosis



The Tei index correlates with mortality, hospitalization, and adverse outcomes in multiple cardiac conditions.



---


Advantages of Tei Index


Simple and quick to obtain


Combines systolic and diastolic function


Geometry-independent


Useful when EF is difficult to assess


Applicable to both LV and RV




---


Limitations


Affected by significant valvular regurgitation


Less reliable in atrial fibrillation


Load-dependent in extreme preload/afterload states


Requires accurate Doppler alignment




---


Key Echo Pearls


↑ Tei index = worse global ventricular function


Normal EF does not exclude abnormal MPI


Particularly useful in RV assessment, where EF estimation is challenging




---


Take-Home Message


The Tei index (MPI) is a robust, Doppler-derived echocardiographic parameter that provides a global snapshot of ventricular performance, complementing conventional systolic and diastolic indices and enhancing risk stratification in everyday echo practice.


Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...